glp-1 and inflammation Anti-inflammatory role of glucagon-like peptide 1 receptor agonists its clinical implications The Therapeutic Potential of GLP-1
Description
Novo puts $285m into monthly GLP-1 based on Ascendis tech Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist
Open 5 , e2231982 (2022)
World J Gastroenterol (2014) 20(43):1622735
In all of these scenarios, medical supervision and metabolic monitoring remain important
2019 Update to: management of hyperglycemia in type 2 Diabetes, 2018
Slimmium helped me stop snacking and start feeling good
